Search results for: Human FGF-4 ELISA (For Lysates) ELISA
#28376106 2017/04/04 To Up
Electrochemical sensor for rapid determination of fibroblast growth factor receptor 4 in raw cancer cell lysates.
The first electrochemical immunosensor for the determination of fibroblast growth factor receptor 4 (FGFR4) biomarker is reported in this work. The biosensor involves a sandwich configuration with covalent immobilization of a specific capture antibody onto activated carboxylic-modified magnetic microcarriers (HOOC-MBs) and amperometric detection at disposable carbon screen-printed electrodes (SPCEs). The biosensor exhibits a great analytical performance regarding selectivity for the target protein and a low LOD of 48.2 pg mL-1. The electrochemical platform was successfully applied for the determination of FGFR4 in different cancer cell lysates without any apparent matrix effect after a simple sample dilution and using only 2.5 μg of the raw lysate. Comparison of the results with those provided by a commercial ELISA kit shows competitive advantages by using the developed immunosensor in terms of simplicity, analysis time, and portability and cost-affordability of the required instrumentation for the accurate determination of FGFR4 in cell lysates.Rebeca M Torrente-Rodríguez, Víctor Ruiz-Valdepeñas Montiel, Susana Campuzano, María Pedrero, Meryem Farchado, Eva Vargas, F Javier Manuel de Villena, María Garranzo-Asensio, Rodrigo Barderas, José M Pingarrón
1962 related Products with: Electrochemical sensor for rapid determination of fibroblast growth factor receptor 4 in raw cancer cell lysates.
2 Pieces/Box100 μg400Tests0.1 mg10 ug0.1 mg96 wells (1 kit)1 kit(96 Wells)96 wells (1 kit)5 x 50 ug100.00 ug5ugRelated Pathways
#14504053 // To Up
Marked increase of the growth factors pleiotrophin and fibroblast growth factor-2 in serum of testicular cancer patients.
Malignant tumors of the testis are among the most common cancers in men between the ages of 15 and 30 years. The sensitivity of detection of known tumor markers depends upon the tumor histology and stage. In other cancers, increased serum concentrations of various angiogenic growth factors have been described as potential markers for tumor progression and metastasis. One main histological feature of testicular cancer is profound angiogenesis.A Aigner, P Brachmann, J Beyer, R Jäger, D Raulais, M Vigny, A Neubauer, A Heidenreich, S Weinknecht, F Czubayko, G Zugmaier
1614 related Products with: Marked increase of the growth factors pleiotrophin and fibroblast growth factor-2 in serum of testicular cancer patients.
100 μg20ug100.00 ug10ug10ug0.1ml (1mg/ml)10ug5ug2ug x 205ug2ug100.00 ugRelated Pathways
Contact Us:
Belgium
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45 Fax 0032 16 50 90 45
[email protected]
France
9, rue Lagrange, 75005 Paris
Tel 01 43 25 01 50 Fax 01 43 25 01 60
[email protected]
Germany
GENTAUR GmbH
Marienbongard 20
52062 Aachen Deutschland
Tel 0241 40 08 90 86 Fax 0241 55 91 05 36
[email protected]
United Kingdom
GENTAUR Ltd.
Howard Frank Turnberry House
1404-1410 High Road
Whetstone London N20 9BH
Tel 020 3393 8531 Fax 020 8445 9411
[email protected]
Also in
Luxembourg +35220880274
Schweiz Züri +41435006251
Danmark +4569918806
Österreich +43720880899
Česká republika Praha +420246019719
Ireland Dublin +35316526556
Norge Oslo +4721031366
Finland Helsset +358942419041
Sverige Stockholm +46852503438
Ελλάς Αθήνα +302111768494
Magyarország Budapest +3619980547
Poland
GENTAUR Poland Sp. z o.o.
ul. Grunwaldzka 88/A m.2
81-771 Sopot, Poland
Tel 058 710 33 44
Fax 058 710 33 48
[email protected]
skype gentaurpoland
Nederland
GENTAUR Nederland BV
Kuiper 1
5521 DG Eersel Nederland
Tel 0208-080893 Fax 0497-517897
[email protected]
Italy
GENTAUR SRL
IVA IT03841300167
Piazza Giacomo Matteotti, 6, 24122 Bergamo
Tel 02 36 00 65 93 Fax 02 36 00 65 94
[email protected]
Spain
GENTAUR Spain
Tel 0911876558
[email protected]
Bulgaria
GENTAUR Bulgaria
53 Iskar Str. 1191 Kokalyane, Sofia
Sofia 1000
Tel 0035924682280
Fax 0035929830072
[email protected]